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Background: Atopic eczema is a common and distressing disease. This study aims to review PubMed indexed
research statistics on atopic eczema over a-10 year period to investigate the clinical relevance and research interest
about this disease.
Methods: PubMed (a service of the U.S. National Library of Medicine) was searched for the terms “atopic
dermatitis” and “eczema”, with limits activated (Humans, Clinical Trial, Meta-Analysis, Randomized Controlled Trial,
English, published in the last 10 years), and editorials, letters, practice guidelines, reviews, and animal studies
excluded. Journal impact factor (IF) is in accordance with Journal Citation Report (JCR) 2009, a product of Thomson
ISI (Institute for Scientific Information).
Results: A total of 890 articles were retrieved. Taking out publications that were irrelevant and those without an
impact factor, 729 articles were obtained. These articles were grouped into dermatology (n = 337, mean IF: 3.01),
allergy/immunology (n = 215, mean IF: 4.89), pediatrics (n = 118, mean IF: 2.53) and miscellaneous subject categories
(n = 142, mean IF: 5.10). The impact factors were highest in the miscellaneous category (p= 0.0001), which includes
such prestigious journals as the New England journal of Medicine (n = 1, IF: 47.05), the Lancet (n = 4, IF: 30.76) and
BMJ (n = 6, IF: 13.66). There was no publication in any family medicine or general practice journal. The British
Journal of Dermatology (n = 78), Pediatric Allergy and Immunology (n = 49) and Journal of Allergy and Clinical
Immunology (n = 46) had the highest number of publications on the subject. Atopic eczema ranked higher in
impact factors in allergy/immunology although more publications appeared in the dermatology category.
Conclusions: Atopic eczema is a multidisciplinary disease. Its clinical relevance and research interests are definitely
beyond that of a mere cutaneous disease. Investigators may consider allergy/immunology and miscellaneous
journal categories for higher impact of their research.
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Childhood eczema is a distressing disease associated
with atopy [1-6]. Disease onset is usually before 5 years
of age in the majority of patients [2,7]. The presence of
atopy, according to the theory of Atopic March, implies
that young children with eczema may develop airway
allergy such as asthma or allergic rhinitis later in life
[5,6,8]. Atopy is defined clinically (personal or family
history of eczema, asthma or allergic rhinitis) and by la-
boratory tests (such as positive skin prick reaction to
common food and aeroallergens or elevated serum IgE* Correspondence: ehon@hotmail.com
1Department of Pediatrics, Prince of Wales Hospital, The Chinese University
of Hong Kong, Clinical Science Building, 6/F, Shatin, Hong Kong
Full list of author information is available at the end of the article
© 2012 Hon et al; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orlevels above laboratory reference range for age) [4,9-11].
This study aims to review PubMed-indexed research
publications statistics on atopic eczema over a-10 year
period to investigate the clinical relevance and research
interests about this disease.Methods
PubMed (a service of the U.S. National Library of Medi-
cine) was searched for the terms “atopic dermatitis” and
“eczema”, with limits activated (Humans, Clinical Trial,
Meta-Analysis, Randomized Controlled Trial, English, pub-
lished in the last 10 years), and editorials, letters, practice
guidelines, reviews, and animal studies excluded. These
limits were set so that the data could be manageable.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Number of publications in the three subject





British Journal of Dermatology 78 4.260
Journal of the American
Academy of Dermatology
33 4.105
Pediatric Dermatology 16 1.031
Contact Dermatitis 9 3.635
Dermatologic Surgery 1 2.343
Skin Pharmacol Physiol 4 2.117
















Dermatologic Therapy 1 1.828
Dermatology 21 2.741
European Journal of Dermatology 5 2.251
Experimental Dermatology 8 3.239
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Citation Report (JCR) 2009, a product of Thomson ISI
(Institute for Scientific Information). Data was expressed as
mean and standard deviation (SD) unless otherwise stated.
ANOVA was used to compare means. All comparisons
were made two-tailed, and p-values less than 0.05 were
considered to be statistically significant.
Results
Between 2001 and 2011 (as of April 2011), a total of 890
articles were retrieved. Each article/journal was reviewed
for relevancy and for an impact factor by Journal Ci-
tation Report JCR 2009. Taking out publications that
are irrelevant and those without an impact factors, 729
articles were obtained. They were classified into derma-
tology, allergy/immunology, pediatrics, and miscellaneous
categories (Table 1). The journal Pediatric Dermatology
was double-counted in both pediatrics and dermatology,
and Paediatric Allergy and Immunology was double-
counted in both pediatrics and allergy/immunology. Inter-
national Journal of Pediatric Otolaryngology, Paediatric
and Perinatal Epidemiology, Pediatric Pulmonology, and
Pediatric Infectious Disease Journal were double-counted
in both pediatrics and miscellaneous. Skin Pharmacology
and Physiology and Dermatologic Surgery were double-
counted in both dermatology and miscellaneous. FEMS Im-
munology and Medical Microbiology, International Journal
of Immunopathology and Pharmacology, Genes and Im-
munity and Seminars in Immunopathology were double
counted in both allergy/immunology and miscellaneous.
These articles were grouped into dermatology (n= 337),
allergy/immunology (n= 215), pediatrics (n= 118) and
miscellaneous subject categories (n= 142) (Table 2). The
impact factors were highest in the miscellaneous category
(p=0.0001). There were a number of prestigious journals
in the miscellaneous category, which included the New
England journal of Medicine (n= 1, IF: 47.05), the Lancet
(n= 4, IF: 30.76) and BMJ (n= 6, IF: 13.66).
Eight publications were under psychiatry/psychology:
Psychotherapy and Psychosomatics (n= 1), Psychosomatic
Medicine (n= 3), The Journal of Behavioral Medicine
(n= 1) and Journal of Psychosomatic Research (n= 3). Five
publications were under integrative and complementary
medicine: Complementary Therapies in Medicine (n= 2),
American Journal of Chinese Medicine (n= 2), Journal of
Alternative and Complement Medicine (n= 2) and Journal
of Ethnopharmacology (n= 1). There was no publication
in any family medicine or general practice journal. The
British Journal of Dermatology (n= 78), Pediatric Allergy
and Immunology (n= 49) and Journal of Allergy and Clin-
ical Immunology (n= 46) had the highest number of pub-
lications on the subject. Atopic eczema ranked higher in
impact factors in allergy/immunology although more pub-
lications appeared in the dermatology category.
Table 2 Indexed publications with impact factors
Category Dermatology Allergy Pediatrics Miscellaneous
Number 337 215 118 142
IF [mean (SD)]* 3.01 (1.47) 4.89 (2.69) 2.53 (1.08) 5.10 (6.55)
95% CI 2.67–3.36 4.46–5.33 1.93–3.11 4.57–5.63
High 5.54 9.17 4.73 47.05
Low 0.46 0.56 0.37 0.51
Median 3.01 4.08 2.68 2.83
*P = 0.0001 by ANOVA.
Table 1 Number of publications in the three subject
categories and their impact factors (Continued)
Allergy and Asthma Proceedings 3 1.796
Annals of Allergy Asthma &
Immunology
10 2.457
Clinical and Expierimental Allergy 34 4.084
Genes and Immunity 1 4.222
Clinical and Experimental Immunology 1 2.550




Journal of Clinical Immunology 1 3.583
Journal of Investigational Allergology
& Clinical Immunology
10 1.189
Contact Dermatitis. 9 3.635







Seminars in Immunopathology 1 9.155
Allergol Immunopathol (Madr). 1 0.630
Pediatrics 118
Pediatric Allergy and Immunology 49 2.676




Paediatr Perinat Epidemiol 2 1.797
Pediatr Infect Disease Journal 1 2.854
Pediatr Pulmonol. 4 1.816
Acta Paediatr 4 1.768
Arch Dis Child 7 2.657
Arch Pediatr Adolesc Medicine 4 4.726
European Journal of Pediatrics 1 1.634
Indian Paediatrics 1 0.962
Journal of Paediatrics and
Child Health
1 1.138
Journal of Pediatrics (Rio J) 2 1.382
Journal of Pediatric Gastroenterology
& Nutrition
5 2.183
Journal of Pediatric Hematology
and Oncology
1 1.022
Journal of Pediatrics 7 4.092
Journal of Tropical Pediatrics 1 1.224
Pediatr Research 2 2.607
Pediatrics 8 4.687
World Journal of Pediatrics 1 0.365
142 publications in miscellaneous category not listed.
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Childhood eczema is a common chronic relapsing dis-
ease [1,2,12] The theory of “atopic march” views eczema
as a systemic atopic disease with skin manifestation inearly childhood, and subsequent airway manifestations
[2,5,8,11]. Our study of more than seven hundred arti-
cles published over a ten-year period showed that
eczema is a clinical entity with diverse research interests.
Although dermatology journals rank top in number,
allergy and medicine journals have higher impact factors
and reflect higher research interests and priority. There
are also publications in the top medical journals with
impact factors above 30, such as the New England Jour-
nal of Medicine and the Lancet. In many Asian cities,
herbal medicine is extensively sought after by many par-
ents and patients in preference to western medicine
[13]. The scope is disproportionately represented by only
few articles in the complementary medicine category
[14]. Eczema contributes a heavy work load for general
practitioners. Surprisingly, no publications were repre-
sented in the family medicine categories.
The limitations of this study are that many advances
in basic research are not represented due to selection
bias of only clinical categories. For instance, filaggrin
and related genome wide studies are published in top
science journals in recent years [15-17]. The number of
articles would be doubled if articles in non-English jour-
nals were also included, which was especially true for
the complementary medicine category [14]. The number
of journals included would certainly increase if a longer
study period, say 20 years, is included. With the search
limits, “case reports” are also included, which tend to be
cited less often than randomized controlled trials and
meta-analyses. As such, journals that publish mainly or
only randomized controlled trials tend to have higher
impact factors.
In dermatology, the “brick-and-mortar hypothesis”
states the stratum corneum (the outermost layer of the
epidermis) normally consists of fully differentiated cor-
neocytes surrounded by a lipid-rich matrix containing
cholesterol, free fatty acids, and ceramide; the structure
of this matrix closely resembles that of bricks and mor-
tar in a wall. In eczema, lipid metabolism is abnormal,
causing a deficiency of ceramide that leads to transepi-
dermal water loss [18-20]. The underlying genetic deficit
might be due to null mutation in the filaggrin gene [17].
Treatment of eczema is primarily with emollient and
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the contrary, the theory of “Atopic March” favors the
consideration of eczema as a systemic disease, and indi-
cates that many children with atopic eczema go on to
develop asthma and allergic rhinitis as their eczema
improves with time [5,6,8]. Nitric oxide (NO) has been
shown to be a marker of airway inflammation. Study has
shown levels of NO in exhaled breath condensate are
higher in children with eczema without asthma, and
may indicate a predictive role of exhaled NO for the de-
velopment of asthma [21]. Atopic eczema has long been
considered as a disease primarily driven by the immune
system [2]. Eosinophils and monocytes are known for
modulating allergic symptoms. Eosinophilia with enhanced
eosinophil survival and elevated eosinophil granule pro-
teins have been detected in AD patients. Overactive mono-
cytes increase the production of prostaglandin E and IL-
10, which alter the balance between Th1 and Th2 func-
tional responses. This accounts for many atopic features
present in eczema patients, including elevated IL-4, 5 and
6 productions by T cell, increased IgE synthesis, reduced
IFN-γ production and impaired cell-mediated immune re-
sponse [2]. The “hygiene hypothesis” further explains the
skewing of immune system towards Th2 profile [22]. Ini-
tial atopic sensitization is thought to take place in utero
where transplacental allergen elicits Th2 response of fetal
lymphocytes. After delivery, while healthy infants switch
their Th2 to Th1 profile by stimulation of infectious
agents, this reversal does not occur in atopic individuals
[23]. Their immunological reaction still favors the Th2
type which reacts to stimulants and results in allergic dis-
ease [24]. Smaller family, improved hygienic strategies,
antibiotic usage etc all lead to reduction of surrounding
microbes and supports this development [2].
In oriental medicine principles, eczema is considered
as a systemic disease with imbalances of Qi or internal
energy [14]. Many Asian patients would think that western
medicine cannot offer a cure, and that topical steroids and
associated treatment have significant side effects [13]. These
principles all favor the concept that eczema is more like a
systemic disease (atopy) with early skin manifestations
(dermatitis) than a skin disease with systemic associations
[5]. Recent research suggested that neutrophils, lympho-
cytes, eosinophils, immunoglobulins and complements are
all important players in the pathophysiology of eczema
[25]. It follows that treating eczema as a primary dermato-
logical disease with only topical armamentarium without
considering managing this complicated disease with a sys-
temic and holistic approach is bound to meet with subopti-
mal effects [26]. Its clinical relevance and research interests
are definitely beyond that of a mere cutaneous disease.Competing interests
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